Child Healthcare at MATER Pediatric Study (CHAMPS)

The overall objective of Child Healthcare at MATER Pediatric Study (CHAMPS) - a single-site 2-arm cluster randomized controlled trial - is to evaluate a group model of well child care for mothers with opioid use disorder and their children. Mother–child dyads in the intervention arm of the study will participate in a group well child care program that is offered on-site at a maternal substance use disorder treatment program. Dyads in the control arm of the study will receive traditional, individual well child care. Dyads in both study arms will be followed prospectively for 18 months, and data will be compared between the two study arms. Primary outcomes include well child care quality and utilization, child health knowledge, and parenting quality. For more information, please contact Dr. Vanessa Short. Project period 2020-2025.

Preparing Opioid Treatment Programs and Providers for Effective Methadone Management Among Pregnant People

The goal of this 2-year project is to provide training and technical assistance to opioid treatment programs around the country to help improve the care they provide to pregnant and parenting women and families. This includes methadone and buprenorphine dosing guidance for pregnancy and postpartum, screening and connecting patients to reproductive health services, and providing parenting supports. Participating opioid treatment programs will receive toolkits, interactive webinars, and peer-to-peer phone consultation over the course of 3-6 months. For more information, please contact Dr. Dennis Hand. Project period July 2024-June 2026.

Doula Support Engagement for Women in OUD Treatment 

The aim of this study, “Doula Support Engagement for Women in OUD Treatment”, is to determine the impact of doula care support (in a population of women in opioid use disorder treatment) on perinatal healthcare utilization, the association with birth outcome and post-partum psychosocial health, and the parenting relationship in the mother child dyad.  For this prospective cohort mixed-methods design study, enrolled participants are followed in the perinatal period (pregnancy through 16 weeks post-partum). This study is also designed within an implementation science framework using the Reach Effectiveness Adoption Implementation Maintenance (RE-AIM) Model, studying intervention administration to increase generalizability to other settings. For more information, please contact Dr. Meghan Gannon. Project period 2022-2025.